NYC VC Fund Launch: Animal Capital Closes $33M Fund III for Consumer Tech
New York-based Animal Capital announced the $33M close of Fund III on June 11, 2026, continuing its early-stage consumer technology investment strategy.
New York is home to a diverse set of venture capital funds spanning seed specialists, multi-stage platforms, and sector-focused investors. Our New York funds coverage helps founders identify the right NYC investors for their stage, sector, and round size.
Explore New York venture capital funds and investor profiles below.
New York-based Animal Capital announced the $33M close of Fund III on June 11, 2026, continuing its early-stage consumer technology investment strategy.
New York-based Star51 Capital announced the first close of its inaugural medtech venture fund on June 11, 2026, anchored by Abbott and Mayo Clinic.
New York-based Dimension Capital filed SEC Form D in June 2026 seeking up to $750M for its third fund, following $350M Fund I and $500M Fund II.
New York-based Blue Cloud Ventures announced the final close of Fund V on June 2, 2026, bringing total AUM above $1 billion for enterprise SaaS and AI growth investing.
New York-based Opto Investments announced the close of its AI-focused venture fund on May 28, 2026, providing RIA and family office clients exposure to foundational AI infrastructure.
Gaingels, the LGBTQ+/allies venture syndicate, crossed $1B deployed across 2,600+ rounds and won the NVCA 2026 Inclusion Impact Award.